Posts for Ticker ‘NRMX’

The 52-Week Low Club

Neurochem (NRMX) Continues to race for the bottom. On Monday, the company said its Alzheimer’s disease treatment candidate, Alzhemed, failed a late-stage trial. The NRMX says it has 15 to 18 months of cash left. Maybe. Drops to $2.16 from 52-week high of $26.51.

Conexant (CNXT) Israel’s Orckit Communications wins arbitration and CNXT has to pay $12 million. Does not seem like a lot but stock drops to $1.06 from 52-week high of $2.36.

Tenet Healthcare (THC) Credit Suisse analyst launched coverage on the company with an "Underperform" rating. Down to $3.29 from 52-week high of $8.69.

Lennar (LEN) Home builder. Enough said. Down to $27.26 from 52-week high of $56.54.

Centex (CTX) Home builder. Ditto. Down to $28.13 from 52-week high of $58.42.

Horton (DHI) Another home builder. Drops to $14.40 from 52-week high of $31.13.

Leapfrog (LF) Bad quarter recently and toy companies are not all the rage right now. Down to $6.91 from 52-week high of $11.56.

Douglas A. McIntyre

Posted on: August 28, 2007 – 3:02 pm in HI/LOW, , , , , , ,

52-Week Lows (August 27, 2007)

Not all of these are low closes but these hit new 52-week lows if not……

Candela (CLZR) keeps hitting the list….

Carmike Cinema’s (CKEC)…if movies hit $4 Billion and they can’t make money then they better jack up thge popcorn prices…..

Chico’s F A S (CHS) put in a new 52-week low intraday, although this sub-$17.00 marks a low if it closes here.

Delta Petroleum (DPTR) may not be a 52-week low close but that was intraday.

Eagle Test Systems Inc. (EGLT) is on that seems to keep hitting the list of late.

Franklin Electric Co., Inc., (FELE)…groundwater and fuel pumping systems… isn’t that supposed to be a hot area???

St. Joe Co. (JOE)…. would you expect anything else from a company that builds small communities and transplant-a-marsh to a town player in this housing and loan environment???

Kellwood (KWD) isn’t selling enough men’s and women’s sportwear?

Neurocham (NRMX)… today’s biotech implosion

Restoration Hardware Inc. (RSTO)… needs to restore itself maybe.  Too bad, because it’s a neat shop.  If houses aren’t selling and if money gets tight, this one can easily be avoided.

Jon C. Ogg
August 27, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: August 27, 2007 – 3:00 pm in HI/LOW, , , , , , , , , ,

Neurochem: Another Failed Small Cap Biotech

Shares in Neurochem (NRMX) are down 30% today to a 52-week low of $3.70.

According to The Associated Press "its Alzheimer’s disease treatment candidate failed in a late-stage clinical trial."

NRMX shares traded as high as $26.51 during the last 52 weeks. Of course, they probably never belonged there. At that share price, the company had a market cap of almost $1.2 billion. Last year, NRMX lost over $66 million on under $3 million in revenue.

The higher share price never made any sense.

Douglas A. McIntyre

Posted on: August 27, 2007 – 10:10 am in Uncategorized,

Alzheimer’s Data Pumps Medivation & Neurochem (MDVN, NRMX)

Some new data is helping two small biotech stocks today at the Alzheimer’s Association International Conference on Prevention of Dementia in Washington, DC.  The latest figure showed 26.6 million people worldwide are living with Alzheimer’s and that figure is expected to quadruple by the year 2050.  In March, the Alzheimer’s Association reported that there are now more than 5 million people in the United States living with Alzheimer’s.

Medivation (MDVN) shares are trading up 30% at what will be a 52-week high after it its Alzheimer’s treatment Dimebon significantly improved symptoms of the disease over one year.  After a one-year mark, patients with mild to moderate Alzheimer’s taking its Dimebon showed benefits in cognition, overall clinical function, normal daily living activities, and improved behavioral problems compared with those patients receiving the placebo.

Neurochem (NRMX) is up over 4% pre-market after release of data on its Alzhemed, although the company readily admits that there is a long ways to go and that the data analysis will still be months away.

In the past we covered some of the Alzheimer’s stocks after a Barron’s piece on the subject, although some of the data from the companies with ‘promising treatments’ has changed.

Here is a full list of the news releases from the conference.

Jon C. Ogg
June 11, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 11, 2007 – 8:29 am in Biotech, ,

Pre-Market Stock News (June 11, 2007)

(ADLR) Adolor said a complete response to the POI ‘Approvable’ Letter now targeted for 3Q 2007.
(ALXN) Alexion Pharm says studies show efficacy and safety of it’s Soliris in broad population of PNH patients in Phase III studies examining Soliris for the treatment of paroxysmal nocturnal hemoglobinuria.
(BYBI) Backyard Burgers agrees to be acquired for $6.50 cash per share.
(CHINA) CDC Corp making a gaming company acquisition.
(CSGS) CSG Systems is paying $23.5M cash to acquire private ComTec.
(CUP) Peru Copper gets a friendly takeover offer from Aluminum of China.
(EME) EMCOR raised guidance and announced a 2-1 stock split.
(ENDO) Endo pharmaceuticals’ FROVA Phase III study data showed short-term prevention treatment reduces frequency and severity of menstrual migraine.
(ERIC) Ericsson in GSM expansion pact with China Mobile.
(GERN) Geron says research indicates its embryonic stem cell based therapy for spinal cord injury evades direct attack response by the human immune system.
(GOOG) Google announced search and ad pact with Sina in China.
(GOL) Gol Intelligent Airlines said Continental will sell its tickets for travel to Brazil and South America.
(IBM) IBM paying close to $750 million to acquire Telogic AB in Sweden.
(IMCL) Imclone said FDA accepted and granted priority review of ERBITUX sBLA for overall survival in patients with advanced colorectal cancer.
(JOSB) Jos. A. Bank $0.45 EPS vs $0.42e.
(MDVN) Medivation’s Dimebon maintains statistically significant benefit on all five efficacy endpoints in Alzheimer’s disease after one year of therapy
(NGA) North American Galvanizing trades ex-split to reflect a 3-2 stock split.
(NRMX) Neurochem presents update on Alzhemed, but said that no predictions or conclusions can yet be made regarding the outcome of the Phase III study.
(OI) Owen-Illinois is selling its plastics unit to rexam for $1.8 Billion.
(OSUR) OraSure received a CE mark of approval from the EU for its OraQuick rapid HIV test.
(PRGS) Progress Software added one of the Dow Jones news feeds to its algorithmic trading platform.
(PRW) Pro-Pharmaceutical submits data to begin a 505B2 filing with FDA for new formulation of Irinotecan for potential cancer treatment indications.
(RIMG) Rimage announced a $6.5M order from new major national retail customer.
(SINA) Sina in strategic search and ad partnership with Google in China.
(TRLG) True Religion CEO reduced holdings of 2.3 million shares in a private placement.

Jon C. Ogg
June 11, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 11, 2007 – 6:48 am in Pre-Market Activity, , , , , , , , , , , , , , , , , , , ,

52-Week Low Club (June 8, 2007)

Stock Tickers: AZN, BCRX, EHTH, CTIC, HW, NRMX, SBUX, WFMI, DUK

It’s no secret we had the makings of a crummy week, but the market managed to turn itself back around after a fairly week open.  Regardles of a bull market or any market, there are still stocks hitting 52-week lows:

AstraZeneca (AZN) ADR’s put in lows, two days after the CFO left to join Goldman Sachs.

BioCryst (BCRX) stays weak, apparently the near-term bounce turned back into a pounce.

Cell Therapeutics (CTIC) managed to keep its post-ASCO slide going.

eHealth, Inc (EHTH) put in the lowest close since its October IPO.

Headwaters (HW) just keeps slipping and looks uglier daily, and has been oin a crash course for about 6 weeks..

Neurochem (NRMX) closed down another 10% after the poor drug outlook yesterday.

Starbucks (SBUX) and Whole Foods (WFMI) were in the 52-week low gutter club earlier but got bailed out by the market offer. Duke Energy (DUK) also rode most of the day on new adjusted lows before an end of day recovery, although these might not be ultimate 52-week lows on an adjusted basis.

Jon C. Ogg
June 8, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Posted on: June 8, 2007 – 3:29 pm in HI/LOW, , , , , , , , ,